Literature DB >> 28429234

Neuron-to-Neuron Transfer of FUS in Drosophila Primary Neuronal Culture Is Enhanced by ALS-Associated Mutations.

Sébastien Feuillette1,2, Morgane Delarue1,2, Gaëtan Riou2,3, Anne-Lise Gaffuri4, Jane Wu5, Zsolt Lenkei4, Olivier Boyer2,3,6, Thierry Frébourg1,2,7, Dominique Campion1,2,8, Magalie Lecourtois9,10.   

Abstract

The DNA- and RNA-binding protein fused in sarcoma (FUS) has been pathologically and genetically linked to amyotrophic lateral sclerosis (ALS) or frontotemporal lobar degeneration (FTLD). Cytoplasmic FUS-positive inclusions were identified in the brain and spinal cord of a subset of patients suffering with ALS/FTLD. An increasing number of reports suggest that FUS protein can behave in a prion-like manner. However, no neuropathological studies or experimental data were available regarding cell-to-cell spread of these pathological protein assemblies. In the present report, we investigated the ability of wild-type and mutant forms of FUS to transfer between neuronal cells. We combined the use of Drosophila models for FUS proteinopathies with that of the primary neuronal cultures to address neuron-to-neuron transfer of FUS proteins. Using conditional co-culture models and an optimized flow cytometry-based methodology, we demonstrated that ALS-mutant forms of FUS proteins can transfer between well-differentiated mature Drosophila neurons. These new observations support that a propagating mechanism could be applicable to FUS, leading to the sequential dissemination of pathological proteins over years.

Entities:  

Keywords:  Drosophila primary neuronal culture; FACS; FUS; Mutations; Spreading

Mesh:

Substances:

Year:  2017        PMID: 28429234     DOI: 10.1007/s12031-017-0908-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

1.  A conditional tissue-specific transgene expression system using inducible GAL4.

Authors:  T Osterwalder; K S Yoon; B H White; H Keshishian
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

2.  A nuclear protein regulated during the transition from active to quiescent phenotype in cultured endothelial cells.

Authors:  M C Alliegro; M A Alliegro
Journal:  Dev Biol       Date:  1996-03-15       Impact factor: 3.582

Review 3.  The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.

Authors:  Lary C Walker; Juliane Schelle; Mathias Jucker
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

Review 4.  Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.

Authors:  Antonia Ratti; Emanuele Buratti
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

5.  Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins.

Authors:  Michael Meissner; Sergiy Lopato; Josef Gotzmann; Georg Sauermann; Andrea Barta
Journal:  Exp Cell Res       Date:  2003-02-15       Impact factor: 3.905

6.  TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines.

Authors:  Ritsuko Fujii; Toru Takumi
Journal:  J Cell Sci       Date:  2005-11-29       Impact factor: 5.285

7.  Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.

Authors:  Daryl A Bosco; Nathan Lemay; Hae Kyung Ko; Hongru Zhou; Chris Burke; Thomas J Kwiatkowski; Peter Sapp; Diane McKenna-Yasek; Robert H Brown; Lawrence J Hayward
Journal:  Hum Mol Genet       Date:  2010-08-10       Impact factor: 6.150

8.  Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation.

Authors:  Takahisa Tateishi; Toshihiro Hokonohara; Ryo Yamasaki; Shiro Miura; Hitoshi Kikuchi; Akiko Iwaki; Hiroshi Tashiro; Hirokazu Furuya; Yuko Nagara; Yasumasa Ohyagi; Nobuyuki Nukina; Toru Iwaki; Yasuyuki Fukumaki; Jun-ichi Kira
Journal:  Acta Neuropathol       Date:  2009-12-05       Impact factor: 17.088

Review 9.  Molecular mechanism of prion-like tau-induced neurodegeneration.

Authors:  Alejandra D Alonso; Cindy Beharry; Christopher P Corbo; Leah S Cohen
Journal:  Alzheimers Dement       Date:  2016-04-25       Impact factor: 21.566

10.  FUS is sequestered in nuclear aggregates in ALS patient fibroblasts.

Authors:  Jacob C Schwartz; Elaine R Podell; Steve S W Han; James D Berry; Kevin C Eggan; Thomas R Cech
Journal:  Mol Biol Cell       Date:  2014-07-09       Impact factor: 4.138

View more
  3 in total

Review 1.  Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.

Authors:  Juan Carlos Polanco; Chuanzhou Li; Liviu-Gabriel Bodea; Ramon Martinez-Marmol; Frederic A Meunier; Jürgen Götz
Journal:  Nat Rev Neurol       Date:  2017-12-15       Impact factor: 42.937

Review 2.  Phenotypic diversity in ALS and the role of poly-conformational protein misfolding.

Authors:  Jacob I Ayers; David R Borchelt
Journal:  Acta Neuropathol       Date:  2020-09-15       Impact factor: 15.887

Review 3.  ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

Authors:  Rita Mejzini; Loren L Flynn; Ianthe L Pitout; Sue Fletcher; Steve D Wilton; P Anthony Akkari
Journal:  Front Neurosci       Date:  2019-12-06       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.